José María Cabrera (@josemariacm_) 's Twitter Profile
José María Cabrera

@josemariacm_

Neurólogo. Unidad de Neuroinmunologia @hospitalclinic. Con la necesidad de aprender para sentir que estoy #viviendo.

ID: 208997341

linkhttps://www.researchgate.net/profile/Jose_Maria_Cabrera-Maqueda calendar_today28-10-2010 10:06:16

22,22K Tweet

2,2K Followers

2,2K Following

Brain (@brain1878) 's Twitter Profile Photo

Maudes et al. present a new mouse model of anti-NMDAR encephalitis, which provides a platform for studying the underlying disease mechanisms and allows testing of treatments over an extended disease course. tinyurl.com/muc9f8fx

Maudes et al. present a new mouse model of anti-NMDAR encephalitis, which provides a platform for studying the underlying disease mechanisms and allows testing of treatments over an extended disease course. tinyurl.com/muc9f8fx
Hospital Clínic (@hospitalclinic) 's Twitter Profile Photo

📅 Aquest dimecres 04 de juny celebrem la XV reunió de familiars i pacients per l'#Esclerosi Múltiple! 🏥Auditori Esteve del CEK ⏰18:00 a 20:00h ⚠️Recordeu que és un acte obert i no cal inscipció. 👍Us hi esperem!

📅 Aquest dimecres 04 de juny celebrem la XV reunió de familiars i pacients per l'#Esclerosi Múltiple!

🏥Auditori Esteve del CEK
⏰18:00 a 20:00h

⚠️Recordeu que és un acte obert i no cal inscipció.

👍Us hi esperem!
Andreu Vilaseca (@andreuvilaseca7) 's Twitter Profile Photo

🟢Major advance in anti-NMDAR encephalitis in 2025H1!🔝 An animal model shows a more complete clinical syndrome (even stereotypes) and brain histopathological dynamics. 💉When Rituximab is added, depletes B cells and symptoms improve. But when B cells return…so do the symptoms!

🟢Major advance in anti-NMDAR encephalitis in 2025H1!🔝
An animal model shows a more complete clinical syndrome (even stereotypes) and brain histopathological dynamics.
💉When Rituximab is added, depletes B cells and symptoms improve. But when B cells return…so do the symptoms!
Neuroimmunology Clinic Barcelona (@neuroimmuclinic) 's Twitter Profile Photo

💡 We have developed a new mouse model for anti-NMDAR encephalitis will indeed deepen the understanding of the disease's pathophysiology and potentially accelerate treatment discovery.

Dr. Brandon Beaber (@brandon_beaber) 's Twitter Profile Photo

For people with existing autoimmune disorders who take immune checkpoint inhibitors, the risk of relapse appears to be much higher with myasthenia gravis (12 of 18 [67%], often severe) vs only 8 of 45 [18%] with multiple sclerosis. Why? pubmed.ncbi.nlm.nih.gov/40465294/

For people with existing autoimmune disorders who take immune checkpoint inhibitors, the risk of relapse appears to be much higher with myasthenia gravis (12 of 18  [67%], often severe) vs only 8 of 45 [18%] with multiple sclerosis.  Why? pubmed.ncbi.nlm.nih.gov/40465294/
Gabriela Sanz L (@gabrielasanzl) 's Twitter Profile Photo

¿Qué opciones no farmacológicas hay en caso de refractariedad a las terapias para CRS/ICANS?. La RPT es una terapia que permite eliminar citocinas de forma aguda. Hematología SantPau Sant Pau - Campus Salut Barcelona #SETS2025 Banc de Sang Sant Pau

¿Qué opciones no farmacológicas hay en caso de refractariedad a las terapias para CRS/ICANS?. La RPT es una terapia que permite eliminar citocinas de forma aguda.
<a href="/hematosantpau/">Hematología SantPau</a> <a href="/HospitalSantPau/">Sant Pau - Campus Salut Barcelona</a> #SETS2025 <a href="/bancsangsantpau/">Banc de Sang Sant Pau</a>
Andreu Vilaseca (@andreuvilaseca7) 's Twitter Profile Photo

🟢📢Towards unified MS diagnostic criteria! This study shows McDonald’s dissemination-in-space criteria already work well at RIS baseline—and baseline CELs boost specificity a lot! 🔜Another key step toward the 2024 McDonald criteria update coming up soon! #MS #Neurology

🟢📢Towards unified MS diagnostic criteria!
This study shows McDonald’s dissemination-in-space criteria already work well at RIS baseline—and baseline CELs boost specificity a lot!

🔜Another key step toward the 2024 McDonald criteria update coming up soon! #MS #Neurology
Andreu Vilaseca (@andreuvilaseca7) 's Twitter Profile Photo

📢 New clue in the pain puzzle: FGFR3 antibodies don’t just mark sensory neuronopathy with neuropathic pain, they cause it! By triggering hyperexcitability in nociceptive neurons, they drive pain sensitivity. Could this be just the tip of the iceberg in autoimmune pain disorders?

📢 New clue in the pain puzzle: FGFR3 antibodies don’t just mark sensory neuronopathy with neuropathic pain, they cause it!
By triggering hyperexcitability in nociceptive neurons, they drive pain sensitivity.
Could this be just the tip of the iceberg in autoimmune pain disorders?
Alberto Vogrig (@vogrig_alberto) 's Twitter Profile Photo

🎯 At #EAN2025 in Helsinki? Don’t miss these key sessions: 🧠 June 23, 8:30–10:00 CAR T cell therapy in neurology (EAN/EANO) ⚠️ June 24, 13:30–17:00 Friendly fire of immunotherapy: Iatrogenic neuroimmunology #neurotwitter #EAN25 #immunotherapy European Academy of Neurology Università di Udine

🎯 At #EAN2025 in Helsinki? Don’t miss these key sessions:

🧠 June 23, 8:30–10:00
CAR T cell therapy in neurology (EAN/EANO)

⚠️ June 24, 13:30–17:00
Friendly fire of immunotherapy: Iatrogenic neuroimmunology

#neurotwitter #EAN25 #immunotherapy
<a href="/EANeurology/">European Academy of Neurology</a> <a href="/uniud/">Università di Udine</a>
Carlos Sabaté Ferré (@carlossabat2) 's Twitter Profile Photo

Soy el padre de Jordi Sabate,que sufre y padece ELA,yo les digo a los responsables de que no llegan las ayudas ,que se imaginen que un hijo suyo sufre ELA,y no pueden sufragar los gastos,mi caso sino fuesen por mis familiares,mi hijo estaría muerto esto es terrible,ya basta.

Carmen Tur (@carmentur1) 's Twitter Profile Photo

Very pleased to share our latest paper! Deep learning to predict progression independent of relapse activity at a first demyelinating event academic.oup.com/braincomms/art… Thanks so much Vall d'Hebron Institut de Recerca Cemcat Mar Tintore Xavier Montalban Alex Rovira D.Pareto X.LLadó LL.Coll Instituto de Salud Carlos III (ISCIII)

Albert Llado (@alladopl) 's Twitter Profile Photo

Una bona oportunitat per unir-se a un grup capdavanter en recerca en demències neurodegeneratives, en un moment amb avenços rellevants en el camp tan a nivell de diagnòstic com tractament. Contacta amb nosaltres.

Lucas Barea (@lucasbarea) 's Twitter Profile Photo

Very grateful to have participated in this study on the therapeutic potential of neural stem cells in remyelination. A great learning experience. 😄

Lluis Montoliu (@lluismontoliu) 's Twitter Profile Photo

Reportan en NEJM el nacimiento de 8 bebés sanos de madres portadoras de #mitocondrias con mutaciones gracias a la técnica de los "tres padres", padre y madre del bebé y otra mujer que aporta las mitocondrias sanas de sus óvulos. En el Reino Unido. nejm.org/doi/full/10.10…

IDIBAPS (@idibaps) 's Twitter Profile Photo

Descobreix el grup ➡️Patogènesi de les malalties neuronals autoimmunes⬅️ liderat per Josep Dalmau El grup estudia com l'autoimmunitat altera l'estructura i la funció de les neurones i els circuits cerebrals Neuroimmunology Clinic Barcelona  👉f.mtr.cool/tdurcxelcx

Andreu Vilaseca (@andreuvilaseca7) 's Twitter Profile Photo

How can we predict treatment response in #MultipleSclerosis before starting therapy? In our latest study in European Academy of Neurology , we identified a genetic variant in NFKB linked to response to interferon-β. 🧬Just one small step toward making personalized medicine a reality. #MSresearch

How can we predict treatment response in #MultipleSclerosis before starting therapy?
In our latest study in <a href="/EANeurology/">European Academy of Neurology</a> , we identified a genetic variant in NFKB linked to response to interferon-β.
🧬Just one small step toward making personalized medicine a reality. #MSresearch